Kingdon Capital Management, L.L.C.
Source: SEC Form 13F · as of Mar 2026Kingdon Capital Management, L.L.C. holds 12 biotech & pharma companies tracked by BioSniper, totaling $134.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$134.7M
| Company | Shares | Value |
|---|---|---|
| SNDXSyndax Pharmaceuticals Inc | 2,500,000 | $58.4M |
| SLNOSOLENO THERAPEUTICS INC | 575,000 | $19.3M |
| OLMAOlema Pharmaceuticals, Inc. | 855,000 | $12.7M |
| ICLRICON plc | 105,300 | $11.7M |
| ACHCAcadia Healthcare Company Inc. | 396,192 | $9.3M |
| ZVRAZEVRA THERAPEUTICS, INC. | 775,000 | $7.2M |
| TVTXTravere Therapeutics, Inc. | 200,000 | $5.9M |
| ALDXAldeyra Therapeutics, Inc. | 2,152,315 | $3.6M |
| ELDNEledon Pharmaceuticals, Inc. | 1,039,275 | $3.2M |
| SCYXSCYNEXIS INC | 1,982,491 | $1.8M |
| JSPRJasper Therapeutics Inc. | 1,352,106 | $1.2M |
| NVNOenVVeno Medical Corporation | 36,166 | $366K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.